Blog

March 23, 2018

Tergus Pharma announces the Acquisition of EnDev Labs

Tergus Has Added Early Development & Skin Biology Capabilities With EnDev Laboratories March 22, 2018 17:10 ET | Source: Tergus Pharma   RESEARCH TRIANGLE PARK, N.C., March 22, 2018 (GLOBE […]
February 3, 2018

Duffy McDonald has joined Tergus in the capacity of Sr. Director, HR and Organizational Effectiveness.

Duffy’s early career began with 3M in the areas of manufacturing, quality systems and human resources. Through this experience Duffy recognized that people are critical to […]
February 18, 2016

Tergus Hires Michele Nathan Borek

The following release just went over the newswire. We are very pleased the Michele Nathan Borek has joined Tergus! Tergus Hires Leading Sales and Marketing Executive […]
February 5, 2016

How Tergus Leads the Industry with In Vitro Release Testing (IVRT)

Some of you may know that Tergus co-founder, Kailas Thakker, was involved in the development of in Vitro Release Testing (IVRT), recognized as an essential testing […]
January 27, 2016

Topical Drug Delivery Considerations for Biologics

Tergus CEO, Dr. Vijendra Nalamothu and Dr. Marc Hens of Tergus co-wrote an article that appeared recently in American Pharmaceutical Review. The article, titled Topical Drug […]
January 18, 2016

Topical Drug Delivery Considerations for Biologics

Vijendra Nalamothu. PhD , Marc Hens PhD. Tergus Pharma According to the analyst firm Global Information, the demand for biologics and biosimilars is estimated to grow to […]
January 18, 2016

Topical Drug Delivery Considerations for Biologics

Vijendra Nalamothu. PhD Marc Hens PhD. Tergus Pharma According to the analyst firm Global Information, the demand for biologics and biosimilars is estimated to grow to […]
January 14, 2016

IVRT Method Development – Simply Put (Part 1)

Ryan Klein, Director R&D at Tergus We have previously touched on the dramatic increase in the use and application of in vitro release testing (IVRT) during […]
January 14, 2016

IVRT Method Development – Simply Put (Part 1)

Ryan Klein, Director R&D at Tergus We have previously touched on the dramatic increase in the use and application of in vitro release testing (IVRT) during […]
December 10, 2015

Tergus Hires Michele Nathan Borek

The following release just went over the newswire. We are very pleased the Michele Nathan Borek has joined Tergus!
September 16, 2015

The Art of Topicals

Yesterday, Tergus CEO, Vijendra Nalamothu opened a master class on Designing Non-Invasive Skin Mediated Therapies, held by Gattefossé. Dr. Nalamothu discussed the importance of the right […]